Crinetics Pharmaceuticals In shares owned by UBS Group
Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Crinetics Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Crinetics Pharmaceuticals In held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crinetics Pharmaceuticals In by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $17M | 408k | 41.65 |
| 2025-06-30 | $9.2M | 321k | 28.76 |
| 2025-03-31 | $11M | 316k | 33.54 |
| 2024-12-31 | $36M | 708k | 51.13 |
| 2024-09-30 | $9.3M | 183k | 51.10 |
| 2024-06-30 | $8.2M | 183k | 44.79 |
| 2024-03-31 | $13M | 268k | 46.81 |
| 2023-12-31 | $4.9M | 139k | 35.58 |
| 2023-09-30 | $2.4M | 82k | 29.74 |
| 2023-06-30 | $2.6M | 146k | 18.00 |
| 2023-03-31 | $950k | 59k | 16.06 |
| 2022-12-31 | $1.5M | 81k | 18.30 |
| 2022-09-30 | $160k | 8.1k | 19.66 |
| 2022-06-30 | $358k | 19k | 18.67 |
| 2022-03-31 | $1.5M | 69k | 22.30 |
| 2021-12-31 | $1.5M | 53k | 27.82 |
| 2021-09-30 | $447k | 21k | 21.06 |
| 2021-03-31 | $63k | 4.1k | 15.23 |
| 2020-12-31 | $30k | 2.1k | 14.29 |
| 2020-06-30 | $159k | 9.1k | 17.49 |
| 2020-03-31 | $121k | 8.2k | 14.73 |
| 2019-12-31 | $429k | 17k | 25.11 |
| 2019-09-30 | $138k | 9.2k | 15.00 |
| 2019-06-30 | $17k | 685 | 24.82 |
| 2019-03-31 | $988k | 43k | 22.76 |
| 2018-12-31 | $18k | 595 | 30.25 |
| 2018-09-30 | $47k | 1.6k | 28.71 |